Page last updated: 2024-09-03

lestaurtinib and Pregnancy

lestaurtinib has been researched along with Pregnancy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kangussu-Marcolino, MM; Singh, U	1

Other Studies

1 other study(ies) available for lestaurtinib and Pregnancy

Article	Year
Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica. Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Animals; Carbazoles; Drug Repositioning; Entamoeba histolytica; Female; Furans; Humans; Imidazoles; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Pregnancy; Pyridazines; TOR Serine-Threonine Kinases	2022

Article

Year

Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica.

Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2

Topics: Animals; Carbazoles; Drug Repositioning; Entamoeba histolytica; Female; Furans; Humans; Imidazoles; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Pregnancy; Pyridazines; TOR Serine-Threonine Kinases

2022